Clinical Trial Update: The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer [Phase 2]

View source ↗

Summary

The document details a Phase 2 clinical trial evaluating 68Ga-DOTATATE-PET/CT imaging for metastatic thyroid cancer. The trial is currently recruiting and spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• 68Ga-DOTATATE-PET/CT (68Ga-DOTATATE)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Metastic Thyroid Cancer | Phase 2 | Status: RECRUITING